Abstract

ACHE, Yamel et al. The best of the 2018 European Society of Cardiology Congress. Rev.Urug.Cardiol. [online]. 2018, vol.33, n.3, pp.131-149. ISSN 0797-0048.  https://doi.org/10.29277/cardio.33.3.10.

The European Congress of Cardiology was held at Munich from August 25th to 29th. Undoubtedly one of the most important and innovative events of the cardiology community, it brought together more than 32.000 professionals, with prominent international guests and multiple scientific activities. In addition to the traditional presentations of studies, ESC 2018 inaugurated a: Digital Health Area, where continuous sessions on E-Cardiology were held with multiple presentations of mobile apps, telemedicine and digital technology for both, the professionals and the community.

The new european guidelines on Arterial Hypertension, awaited after the discussion related with the American guidelines in 2017, were presented. European blood pressure guidelines will stick with the 140/90 mmHg diagnostic threshold and will focus on improving control rates through initial two-drug antihypertensive combinations for most patients.

We will make a brief summary of some of the main scientific trials presented:

- Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease: ARRIVE.

- Coronary CT Angiography and 5-Year Risk of Myocardial Infarction: The SCOT-HEART Investigators.

- Partial Oral Treatment of Endocarditis: POET.

- Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: GLOBAL LEADERS.

- One-Year Outcomes after PCI Strategies in Cardiogenic Shock: CULPRIT-SHOCK

Keywords : Primary prevention; Coronary Angiography; Computed Tomography Angiography; Infarction; Endocarditis; Drug- Eluting Stents; Cardiogenic; Shock.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )